메뉴 건너뛰기




Volumn 27, Issue 2, 2007, Pages 182-187

The influence of galantamine on reaction time, attention processes, and performance variability in elderly Alzheimer patients

Author keywords

[No Author keywords available]

Indexed keywords

GALANTAMINE;

EID: 34247105002     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318032eadb     Document Type: Article
Times cited : (13)

References (43)
  • 1
    • 0034643928 scopus 로고    scopus 로고
    • Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group
    • Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54:S4-S9.
    • (2000) Neurology , vol.54
    • Lobo, A.1    Launer, L.J.2    Fratiglioni, L.3
  • 2
    • 0033048997 scopus 로고    scopus 로고
    • Attention and executive deficits in Alzheimer's disease. A critical review
    • Perry RJ, Hodges JR. Attention and executive deficits in Alzheimer's disease. A critical review. Brain. 1999;122(Pt 3):383-404.
    • (1999) Brain , vol.122 , Issue.PART 3 , pp. 383-404
    • Perry, R.J.1    Hodges, J.R.2
  • 3
    • 0033991494 scopus 로고    scopus 로고
    • The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: Relationship to episodic and semantic memory impairment
    • Perry RJ, Watson P, Hodges JR. The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment. Neuropsychologia. 2000;38:252-271.
    • (2000) Neuropsychologia , vol.38 , pp. 252-271
    • Perry, R.J.1    Watson, P.2    Hodges, J.R.3
  • 4
    • 3242735592 scopus 로고    scopus 로고
    • Selective attention impairments in Alzheimer's disease: Evidence for dissociable components
    • Levinoff EJ, Li KZ, Murtha S, et al. Selective attention impairments in Alzheimer's disease: evidence for dissociable components. Neuropsychology. 2004;18:580-588.
    • (2004) Neuropsychology , vol.18 , pp. 580-588
    • Levinoff, E.J.1    Li, K.Z.2    Murtha, S.3
  • 5
    • 0034901461 scopus 로고    scopus 로고
    • Attentional control in Alzheimer's disease
    • Baddeley AD, Baddeley HA, Bucks RS, et al. Attentional control in Alzheimer's disease. Brain. 2001;124:1492-1508.
    • (2001) Brain , vol.124 , pp. 1492-1508
    • Baddeley, A.D.1    Baddeley, H.A.2    Bucks, R.S.3
  • 6
    • 33745602724 scopus 로고    scopus 로고
    • Attentional processes discriminate between patients with mild Alzheimer's disease and cognitively healthy elderly
    • Gorus E, De Raedt R, Lambert M, et al. Attentional processes discriminate between patients with mild Alzheimer's disease and cognitively healthy elderly. Int Psychogeriatr. 2006;18:539-549.
    • (2006) Int Psychogeriatr , vol.18 , pp. 539-549
    • Gorus, E.1    De Raedt, R.2    Lambert, M.3
  • 7
    • 0017034195 scopus 로고
    • Reaction time as a diagnostic measure in senility
    • Ferris S, Crook T, Sathananthan G, et al. Reaction time as a diagnostic measure in senility. J Am Geriatr Soc. 1976;24:529-533.
    • (1976) J Am Geriatr Soc , vol.24 , pp. 529-533
    • Ferris, S.1    Crook, T.2    Sathananthan, G.3
  • 8
    • 33745613485 scopus 로고    scopus 로고
    • Diversity, dispersion and inconsistency of reaction time measures: Effects of age and task complexity
    • Gorus E, De Raedt R, Mets T. Diversity, dispersion and inconsistency of reaction time measures: effects of age and task complexity. Aging Clin Exp Res. 2006;18:407-417.
    • (2006) Aging Clin Exp Res , vol.18 , pp. 407-417
    • Gorus, E.1    De Raedt, R.2    Mets, T.3
  • 9
    • 0031683898 scopus 로고    scopus 로고
    • Cognitive and motor slowing in Alzheimer's disease and geriatric depression
    • Nebes RD, Halligan EM, Rosen J, et al. Cognitive and motor slowing in Alzheimer's disease and geriatric depression. J Int Neuropsychol Soc. 1998;4:426-434.
    • (1998) J Int Neuropsychol Soc , vol.4 , pp. 426-434
    • Nebes, R.D.1    Halligan, E.M.2    Rosen, J.3
  • 10
    • 10244259208 scopus 로고    scopus 로고
    • The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group
    • Rogers SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group. Dementia. 1996;7:293-303.
    • (1996) Dementia , vol.7 , pp. 293-303
    • Rogers, S.L.1    Friedhoff, L.T.2
  • 11
    • 0031883716 scopus 로고    scopus 로고
    • A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group
    • Rogers SL, Farlow MR, Doody RS, et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology. 1998;50:136-145.
    • (1998) Neurology , vol.50 , pp. 136-145
    • Rogers, S.L.1    Farlow, M.R.2    Doody, R.S.3
  • 12
    • 0034720816 scopus 로고    scopus 로고
    • Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group
    • Raskind MA, Peskind ER, Wessel T, et al. Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology. 2000;54:2261-2268.
    • (2000) Neurology , vol.54 , pp. 2261-2268
    • Raskind, M.A.1    Peskind, E.R.2    Wessel, T.3
  • 13
    • 3042858052 scopus 로고    scopus 로고
    • Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease
    • Ritchie CW, Ames D, Clayton T, et al. Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease. Am J Geriatr Psychiatry. 2004;12:358-369.
    • (2004) Am J Geriatr Psychiatry , vol.12 , pp. 358-369
    • Ritchie, C.W.1    Ames, D.2    Clayton, T.3
  • 14
    • 0034720864 scopus 로고    scopus 로고
    • A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group
    • Tariot PN, Solomon PR, Morris JC, et al. A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. Neurology. 2000;54:2269-2276.
    • (2000) Neurology , vol.54 , pp. 2269-2276
    • Tariot, P.N.1    Solomon, P.R.2    Morris, J.C.3
  • 15
    • 0033528436 scopus 로고    scopus 로고
    • Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial
    • Rosler M, Anand R, Cicin-Sain A, et al. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ. 1999;318:633-638.
    • (1999) BMJ , vol.318 , pp. 633-638
    • Rosler, M.1    Anand, R.2    Cicin-Sain, A.3
  • 16
    • 0029092685 scopus 로고
    • Alzheimer disease, attention, and the cholinergic system
    • Lawrence AD, Sahakian BJ. Alzheimer disease, attention, and the cholinergic system. Alzheimer Dis Assoc Disord. 1995;9(suppl 2):43-49.
    • (1995) Alzheimer Dis Assoc Disord , vol.9 , Issue.SUPPL. 2 , pp. 43-49
    • Lawrence, A.D.1    Sahakian, B.J.2
  • 17
    • 15444361108 scopus 로고    scopus 로고
    • Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease
    • Sabbagh MN, Reid RT, Corey-Bloom J, et al. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease. J Neural Transm. 1998;105:709-717.
    • (1998) J Neural Transm , vol.105 , pp. 709-717
    • Sabbagh, M.N.1    Reid, R.T.2    Corey-Bloom, J.3
  • 18
    • 0035251675 scopus 로고    scopus 로고
    • Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease
    • Maelicke A, Samochocki M, Jostock R, et al. Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease. Biol Psychiatry. 2001;49:279-288.
    • (2001) Biol Psychiatry , vol.49 , pp. 279-288
    • Maelicke, A.1    Samochocki, M.2    Jostock, R.3
  • 19
    • 3142731609 scopus 로고    scopus 로고
    • Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: Results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01)
    • Caramelli P, Chaves ML, Engelhardt E, et al. Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01). Arq Neuropsiquiatr. 2004;62:379-384.
    • (2004) Arq Neuropsiquiatr , vol.62 , pp. 379-384
    • Caramelli, P.1    Chaves, M.L.2    Engelhardt, E.3
  • 20
    • 25444471064 scopus 로고    scopus 로고
    • Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease
    • Vellas B, Cunha L, Gertz HJ, et al. Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease. Curr Med Res Opin. 2005;21:1423-1429.
    • (2005) Curr Med Res Opin , vol.21 , pp. 1423-1429
    • Vellas, B.1    Cunha, L.2    Gertz, H.J.3
  • 21
    • 0016823810 scopus 로고
    • Mini-Mental State A practical method for grading the cognitive state of patients for the clinician
    • Folstein M, Folstein S, McHugh P. "Mini-Mental State" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
    • (1975) J Psychiatr Res , vol.12 , pp. 189-198
    • Folstein, M.1    Folstein, S.2    McHugh, P.3
  • 22
    • 0019967975 scopus 로고
    • The Global Deterioration Scale for assessment of primary degenerative dementia
    • Reisberg B, Ferris SH, de Leon MJ, et al. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136-1139.
    • (1982) Am J Psychiatry , vol.139 , pp. 1136-1139
    • Reisberg, B.1    Ferris, S.H.2    de Leon, M.J.3
  • 23
    • 1642572165 scopus 로고
    • Studies of illness in the aged. The Index of ADL: A standardized measure of biological and psychosocial function
    • Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
    • (1963) JAMA , vol.185 , pp. 914-919
    • Katz, S.1    Ford, A.B.2    Moskowitz, R.W.3
  • 24
    • 0020047111 scopus 로고
    • A research and service oriented multilevel assessment instrument
    • Lawton MP, Moss M, Fulcomer M, et al. A research and service oriented multilevel assessment instrument. J Gerontol. 1982;37:91-99.
    • (1982) J Gerontol , vol.37 , pp. 91-99
    • Lawton, M.P.1    Moss, M.2    Fulcomer, M.3
  • 25
    • 0026691397 scopus 로고
    • A brief depression scale for use in the medically ill
    • Koenig HG, Cohen HJ, Blazer DG, et al. A brief depression scale for use in the medically ill. Int J Psychiatry Med. 1992;22:183-195.
    • (1992) Int J Psychiatry Med , vol.22 , pp. 183-195
    • Koenig, H.G.1    Cohen, H.J.2    Blazer, D.G.3
  • 26
    • 0027985334 scopus 로고
    • The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
    • Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
    • (1994) Neurology , vol.44 , pp. 2308-2314
    • Cummings, J.L.1    Mega, M.2    Gray, K.3
  • 27
    • 0033973372 scopus 로고    scopus 로고
    • Assessment of dementia in elderly outpatients: A comparative study of European centers and consensus statement
    • Mets T, Monsch AU, Kellett J, et al. Assessment of dementia in elderly outpatients: a comparative study of European centers and consensus statement. Arch Gerontol Geriatr. 2000;30:17-24.
    • (2000) Arch Gerontol Geriatr , vol.30 , pp. 17-24
    • Mets, T.1    Monsch, A.U.2    Kellett, J.3
  • 28
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
    • McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
    • (1984) Neurology , vol.34 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3
  • 29
    • 0017797470 scopus 로고
    • Long-term recovery of visual reaction time after closed head injury
    • Van Zomeren AH, Deelman BG. Long-term recovery of visual reaction time after closed head injury. J Neurol Neurosurg Psychiatry. 1978;41:452-457.
    • (1978) J Neurol Neurosurg Psychiatry , vol.41 , pp. 452-457
    • Van Zomeren, A.H.1    Deelman, B.G.2
  • 30
    • 0034540949 scopus 로고    scopus 로고
    • The relationship between cognitive/neuropsychological factors and car driving performance in older adults
    • De Raedt R, Ponjaert-Kristoffersen I. The relationship between cognitive/neuropsychological factors and car driving performance in older adults. J Am Geriatr Soc. 2000;48:1664-1668.
    • (2000) J Am Geriatr Soc , vol.48 , pp. 1664-1668
    • De Raedt, R.1    Ponjaert-Kristoffersen, I.2
  • 32
    • 0033473813 scopus 로고    scopus 로고
    • Individual differences in speed of mental processing and human cognitive abilities: Toward a taxonomic model
    • Roberts RD, Stankov L. Individual differences in speed of mental processing and human cognitive abilities: toward a taxonomic model. Learn Individ Differ. 1999;11:1-120.
    • (1999) Learn Individ Differ , vol.11 , pp. 1-120
    • Roberts, R.D.1    Stankov, L.2
  • 34
    • 32144440086 scopus 로고    scopus 로고
    • Intraindividual variability as a marker of neurological dysfunction: A comparison of Alzheimer's disease and Parkinson's disease
    • Burton CL, Strauss E, Hultsch DF, et al. Intraindividual variability as a marker of neurological dysfunction: a comparison of Alzheimer's disease and Parkinson's disease. J Clin Exp Neuropsychol. 2006;28:67-83.
    • (2006) J Clin Exp Neuropsychol , vol.28 , pp. 67-83
    • Burton, C.L.1    Strauss, E.2    Hultsch, D.F.3
  • 35
    • 0033774599 scopus 로고    scopus 로고
    • Intraindividual variability in cognitive performance in older adults: Comparison of adults with mild dementia, adults with arthritis, and healthy adults
    • Hultsch DF, MacDonald SW, Hunter MA, et al. Intraindividual variability in cognitive performance in older adults: comparison of adults with mild dementia, adults with arthritis, and healthy adults. Neuropsychology. 2000;14:588-598.
    • (2000) Neuropsychology , vol.14 , pp. 588-598
    • Hultsch, D.F.1    MacDonald, S.W.2    Hunter, M.A.3
  • 36
    • 0017565917 scopus 로고
    • Reaction time variability in epileptic and brain-damaged patients
    • Bruhn P, Parsons OA. Reaction time variability in epileptic and brain-damaged patients. Cortex. 1977;13:373-384.
    • (1977) Cortex , vol.13 , pp. 373-384
    • Bruhn, P.1    Parsons, O.A.2
  • 37
    • 0029837999 scopus 로고    scopus 로고
    • Visual reaction time and its relationship to neuropsychological test performance
    • Collins LF, Long CJ. Visual reaction time and its relationship to neuropsychological test performance. Arch Clin Neuropsychol. 1996;11:613-623.
    • (1996) Arch Clin Neuropsychol , vol.11 , pp. 613-623
    • Collins, L.F.1    Long, C.J.2
  • 38
    • 0003250474 scopus 로고
    • The biological basis of intelligence. Part 1: Theory
    • Eysenck HJ, ed, Berlin: Springer-Verlag;
    • Hendrickson AE. The biological basis of intelligence. Part 1: Theory. In: Eysenck HJ, ed. A Model for Intelligence. Berlin: Springer-Verlag; 1982:151-196.
    • (1982) A Model for Intelligence , pp. 151-196
    • Hendrickson, A.E.1
  • 39
    • 0036343311 scopus 로고    scopus 로고
    • Lapses of intention and performance variability reveal age-related increases in fluctuations of executive control
    • West R, Murphy KJ, Armilio ML, et al. Lapses of intention and performance variability reveal age-related increases in fluctuations of executive control. Brain Cogn. 2002;49:402-419.
    • (2002) Brain Cogn , vol.49 , pp. 402-419
    • West, R.1    Murphy, K.J.2    Armilio, M.L.3
  • 40
    • 0027569681 scopus 로고    scopus 로고
    • Bunce DJWP, Cochrane T. Blocks in choice responding as a function of age and physical fitness. Psychol Aging. 2001;8:26-33.
    • Bunce DJWP, Cochrane T. Blocks in choice responding as a function of age and physical fitness. Psychol Aging. 2001;8:26-33.
  • 41
    • 1842784019 scopus 로고    scopus 로고
    • Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: A consensus report
    • Ferrucci L, Guralnik JM, Studenski S, et al. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc. 2004;52:625-634.
    • (2004) J Am Geriatr Soc , vol.52 , pp. 625-634
    • Ferrucci, L.1    Guralnik, J.M.2    Studenski, S.3
  • 42
  • 43
    • 0001607192 scopus 로고
    • Use of the cognitive drug research computerised assessment system to measure the efficacy of THA and galantamine in Alzheimer's disease
    • Wesnes KASM, Boyle M, Surmon DJ, et al. Use of the cognitive drug research computerised assessment system to measure the efficacy of THA and galantamine in Alzheimer's disease. Psychopharmacol Bull. 1994;30:139.
    • (1994) Psychopharmacol Bull , vol.30 , pp. 139
    • Wesnes, K.A.S.M.1    Boyle, M.2    Surmon, D.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.